Your VAT payback opportunity: Further clarifications provided by the Italian tax authorities on the VAT deduction related to the pharmaceutical payback

With the Ruling reply no. 440/2022 dated 29th August 2022, the Italian tax authorities provided clarifications with reference to a case submitted by a taxpayer related to the the possibility of recovering the VAT included in payback amount[1], according to the Law Decree no. 78/2015, on the procedures related to the years 2015 and 2020, for which, as a matter of prudence, the relevant VAT had not been deducted by the taxpayer.

The payback subject to the ruling is not among those expressly regulated by the Budget Law for the year 2018 (Law no. 205/2017), by the article 1, paragraph 394, letters a) and b)[2], but it is referred to the price reduction that pharmaceutical companies shall grant to the Regions in particular circumstances, in order to allow one of their pharmaceutical products not to be included in the C category, i.e. the category of products for which the National Health Service does not refund the expenditure incurred by the citizen. For this type of payback, the possibility of VAT recovery does not appear to be specifically regulated, either by positive law or by previous Italian tax authorities’ guidelines.

Read full post: https://blog.pwc-tls.it/en/2022/09/09/further-clarifications-provided-by-the-italian-tax-authorities-on-the-vat-deduction-related-to-the-pharmaceutical-payback/

Get in touch

Felice De Lillo, Partner, PwC Italy
felice.de.lillo@pwc.com

Davide Accorsi, Director, PwC Italy
davide.accorsi@pwc.com

Dr. Sandra Ragaz, Partner, PwC Switzerland
sandra.ragaz@pwc.ch

Sara Regales Alvarez, Manager, PwC Switzerland
sara.regales.alvarez@pwc.ch

Photo by Braden Collum on Unsplash

Pharma & Life Sciences: 4 cutting edge digital tax & regulatory solutions

Discover PwC’s four cutting edge digital tax & regulatory solutions and how they can add value to your business, help you complying with new laws, stay up to date with upcoming changes in legislation and regulatory.

Continue reading Pharma & Life Sciences: 4 cutting edge digital tax & regulatory solutions